Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma

Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J.H. Shih, Dianna C. Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N. Ray, Eric Bouffet, André O. Von Bueren, David T.W. Jones, Paul A. Northcott, Marcel Kool, Dominik Sturm, Trevor J. Pugh, Scott L. Pomeroy, Yoon Jae Cho, Torsten Pietsch, Marco GessiStefan Rutkowski, Laszlo Bognar, Almos Klekner, Byung Kyu Cho, Seung Ki Kim, Kyu Chang Wang, Charles G. Eberhart, Michelle Fevre-Montange, Maryam Fouladi, Pim J. French, Max Kros, Wieslawa A. Grajkowska, Nalin Gupta, William A. Weiss, Peter Hauser, Nada Jabado, Anne Jouvet, Shin Jung, Toshihiro Kumabe, Boleslaw Lach, Jeffrey R. Leonard, Joshua B. Rubin, Linda M. Liau, Luca Massimi, Ian F. Pollack, Young Shin Ra, Erwin G. Van Meir, Karel Zitterbart, Ulrich Schüller, Rebecca M. Hill, Janet C. Lindsey, Ed C. Schwalbe, Simon Bailey, David W. Ellison, Cynthia Hawkins, David Malkin, Steven C. Clifford, Andrey Korshunov, Stefan Pfister, Michael D. Taylor, Uri Tabori

Research output: Contribution to journalArticlepeer-review

233 Scopus citations

Fingerprint Dive into the research topics of 'Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences